Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response
Authors:
- 1 January 2021
- journal article
- letter
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 27 (1) , 138-140
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real worldNew Microbes and New Infections, 2020
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19Annals of Internal Medicine, 2020
- Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19International Journal of Infectious Diseases, 2020
- Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyCancer Discovery, 2020
- Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled TrialClinical Infectious Diseases, 2020
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19Asian Journal of Medicine and Health, 2020
- Concentration-dependent mortality of chloroquine in overdoseeLife, 2020
- Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysisTravel Medicine and Infectious Disease, 2020
- Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trialJournal of Antimicrobial Chemotherapy, 2020
- Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analysesJournal of Clinical Epidemiology, 2016